Most of the research right now is preclinical with some early clinical data, so clinicians and patients should consider GHK-Cu a hopeful adjunct, not a sure bet therapy
The peptides, popular in wellness circles but lacking strong clinical evidence, include BPC-157, KPV, TB-500, and MOT-c
Book a Free Consultation Peptide therapy is one of the most personalized tools in wellness medicine, and the right protocol depends entirely on what you're trying to achieve
Some research suggests that AHK-Cu could be more potent in activating specific pathways related to collagen production, potentially leading to more pronounced effects on skin firmness and elasticity
Extending Phase 2 from four weeks to six or eight weeks is better than pushing to Phase 3 while still struggling with nausea at 0.5mg